Monoclonal Antibody-Fc engineered

A monoclonal antibody-Fc engineered is a mAb designed to induce cytotoxicity against B-cell malignancies by antibody effector functions mediated via their fragment crystallizable (Fc) region. Fc region, which naturally exists in mAbs, can have unique properties and thereby be potentially used for different applications. Due to these unique properties, various Fc-engineering antibodies have been developed lately in order to enhance the anti-tumor potential of mAbs.

Showing all 2 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
1
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
PD-L1
Monoclonal Antibody-Fc engineered
Tecentriq®
60 mg/mL
yes
12 mg
-80°C
03/2022
262,80 
view product
Max: 10
Min: 2
Step: 1
PD-L1
Monoclonal Antibody-Fc engineered
Tecentriq®
60 mg/mL
yes
12 mg
-80°C
05/2023
262,80 
view product
Max: 3
Min: 2
Step: 1

Not looking for Monoclonal Antibody-Fc engineered?

Search our therapeutic molecules product database